Introduction
The Revenue Cycle Management ((RCM)) Industry continues to grow at a CAGR of 13% and is expected to reach 53 billion by 2023. For those of you who follow my investing strategy, I aim to identify disruptors in growing industries that meet the following criteria: strong competitive advantage, strong revenue growth, rapidly increasing EPS growth, and guidance towards continued exponential growth for years to come. Considering the aforementioned filters the company that I feel has the most upside in the revenue cycle management industry is MTBC.
MTBC, formerly Medical Transcription Billing Corp., (NASDAQ:MTBC